Idenix Pharmaceuticals (IDIX)

[hansfinans]

<Who is selling all these shares at these basement prices?>

A wide range of disappointed investors who has lost faith in the development and the potential of the company.

This year the share price of IDIX has dropped more than 50% and this is despite of the long waited agreement with Glaxo.

At the same time NASDAQ has soared by more than 25%.

So Idenix has been a really poor investment and the management team has to come up with something better. To me they appear to smugly and laid-back.